Ascentage Pharma Group International Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Chief Medical Officer Yifan Zhai reported the acquisition and vesting of restricted stock units and options in Ascentage Pharma Group International.
NASDAQ
Ascentage Pharma Group International Chairman and CEO Dajun Yang disclosed the acquisition and vesting of restricted stock units and options in a recent SEC Form 4 filing.
NASDAQ
Ascentage Pharma Group International's Chief Financial Officer, Veet Misra, reported the vesting of 18,584 restricted stock units on April 20, 2026.